Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Skin Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00816374
What this trial is testing

Tailored Intervention for Melanoma Patient's Families

Who this might be right for
Melanoma
Fox Chase Cancer Center 553
Early research (Phase 1)Looking for participantsNCT04318678
What this trial is testing

CD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML)

Who this might be right for
AML/MDSB-ALLT-ALL+1 more
St. Jude Children's Research Hospital 108
Not applicableStudy completedNCT01482260
What this trial is testing

Comparative Microarray Analysis in Primary Cutaneous Malignant Melanoma

Who this might be right for
Cutaneous Malignant Melanoma
Ruhr University of Bochum 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT03449108
What this trial is testing

LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas

Who this might be right for
Bone SarcomaDedifferentiated ChondrosarcomaGiant Cell Tumor of Bone+13 more
M.D. Anderson Cancer Center 30
Not applicableStudy completedNCT00341991
What this trial is testing

Molecular Epidemiology of Cutaneous Malignant Melanoma

Who this might be right for
Melanoma
National Cancer Institute (NCI) 15,401
Large-scale testing (Phase 3)Study completedNCT00005590
What this trial is testing

Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerExtragonadal Germ Cell Tumor+7 more
Cancer Research Campaign Clinical Trials Centre
Testing effectiveness (Phase 2)Study completedNCT02431676
What this trial is testing

Survivorship Promotion In Reducing IGF-1 Trial

Who this might be right for
Breast CancerProstate CancerLung Cancer+8 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 121
Not applicableEnded earlyNCT02664389
What this trial is testing

Targeted Next-generation Sequencing Panel for Identification of Germline Mutations in Early Onset Cancers With Sporadic or Hereditary Presentation

Who this might be right for
Breast CancerOvarian CancerColorectal Cancer+2 more
University Hospital, Rouen 289
Not applicableStudy completedNCT07431489
What this trial is testing

Retinal Structural and Functional Changes in Patients Treated With BRAF/MEK Inhibitors

Who this might be right for
Malignant MelanomaMEK Inhibitor-Associated Retinopathy
Institute of Oncology Ljubljana 30
Early research (Phase 1)Study completedNCT01709435
What this trial is testing

Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid Tumors

Who this might be right for
Recurrent Malignant Solid NeoplasmRecurrent MelanomaRecurrent Primary Central Nervous System Neoplasm+4 more
National Cancer Institute (NCI) 41
Testing effectiveness (Phase 2)Study completedNCT00445458
What this trial is testing

HKI-272 (Neratinib) in Combination With Paclitaxel (Taxol) in Subjects With Solid Tumors and Breast Cancer

Who this might be right for
Advanced Breast CancerAdvanced Malignant Solid TumorsBreast Neoplasms
Puma Biotechnology, Inc. 110
Testing effectiveness (Phase 2)Looking for participantsNCT06855524
What this trial is testing

Fucoidan for Preventing Chemotherapy-Related Fatigue in Patients With Gastrointestinal, Gynecological, Breast, or Lung Cancer

Who this might be right for
Malignant Digestive System NeoplasmMalignant Female Reproductive System NeoplasmBreast Carcinoma+2 more
Mayo Clinic 34
Testing effectiveness (Phase 2)Ended earlyNCT02974803
What this trial is testing

Concurrent Dabrafenib + Trametinib With Sterotactic Radiation in BRAF Mutation-Positive Malignant Melanoma and Brain Metastases

Who this might be right for
MelanomaBrain Metastases
Canadian Cancer Trials Group 6
Testing effectiveness (Phase 2)Study completedNCT00397579
What this trial is testing

DT388IL3 Fusion Protein in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes

Who this might be right for
LeukemiaMyelodysplastic SyndromesBlastic Plasmacytoid Dendritic Cell Neoplasm
University of Texas Southwestern Medical Center 11
Not applicableNot Yet RecruitingNCT06154590
What this trial is testing

Anastrozole Adjuvant Trial - Study of Anastrozole Compared to NOLVADEX (Tamoxifen Citrate) for Adjuvant Treatment of Early Breast Cancer Clinical Studies), Adjunct Cytotoxic Chemotherapy and Malignant Joint Tumor

Who this might be right for
Metastatic Breast CancerTumorMuscle Neoplasms+1 more
DR. DIANE CHISESI NFS. MD. PHD. 100
Not applicableStudy completedNCT00003404
What this trial is testing

Radiation Therapy After Surgery in Treating Women With Phyllodes Tumor of the Breast

Who this might be right for
Breast Cancer
Dartmouth-Hitchcock Medical Center 46
Early research (Phase 1)Study completedNCT00179608
What this trial is testing

Study of the Combination of Lenalidomide and DTIC (Dacarbazine) in Patients With Metastatic Malignant Melanoma Previously Untreated With Systemic Chemotherapy

Who this might be right for
Malignant Melanoma
Celgene 28
Early research (Phase 1)Study completedNCT00095108
What this trial is testing

Study of Interleukin-21 for Metastatic Malignant Melanoma and Metastatic Kidney Cancer

Who this might be right for
MelanomaKidney NeoplasmsMetastases
ZymoGenetics 43
Not applicableEnded earlyNCT06315296
What this trial is testing

An Interactive Time-Restricted Diet Intervention (txt4fasting) for Reducing Neurocognitive Decline and Improving Survival in Patients With Brain Metastases From Breast or Lung Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaMetastatic Lung Carcinoma+2 more
Thomas Jefferson University 1
Testing effectiveness (Phase 2)Study completedNCT00041808
What this trial is testing

Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver

Who this might be right for
Metastases, NeoplasmColorectal NeoplasmsEsophageal Neoplasms+9 more
FeRx 20
Next Page